[HTML][HTML] Potential treatments for COVID-19; a narrative literature review
A Rismanbaf - Archives of academic emergency medicine, 2020 - ncbi.nlm.nih.gov
SARS-CoV-2 is a newly emerging human infectious coronavirus that causes COVID-19,
which has been recognized as a pandemic by the World Health Organization (WHO) on …
which has been recognized as a pandemic by the World Health Organization (WHO) on …
Lessons from the COVID-19 pandemic for advancing computational drug repurposing strategies
Responding quickly to unknown pathogens is crucial to stop uncontrolled spread of
diseases that lead to epidemics, such as the novel coronavirus, and to keep protective …
diseases that lead to epidemics, such as the novel coronavirus, and to keep protective …
Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents
V Mody, J Ho, S Wills, A Mawri, L Lawson… - Communications …, 2021 - nature.com
Emerging outbreak of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
infection is a major threat to public health. The morbidity is increasing due to lack of SARS …
infection is a major threat to public health. The morbidity is increasing due to lack of SARS …
Structural and evolutionary analysis indicate that the SARS-CoV-2 Mpro is a challenging target for small-molecule inhibitor design
M Bzówka, K Mitusińska, A Raczyńska… - International Journal of …, 2020 - mdpi.com
The novel coronavirus whose outbreak took place in December 2019 continues to spread at
a rapid rate worldwide. In the absence of an effective vaccine, inhibitor repurposing or de …
a rapid rate worldwide. In the absence of an effective vaccine, inhibitor repurposing or de …
Virtual screening, molecular dynamics and structure–activity relationship studies to identify potent approved drugs for Covid-19 treatment
Computer-aided drug screening by molecular docking, molecular dynamics (MD) and
structural–activity relationship (SAR) can offer an efficient approach to identify promising …
structural–activity relationship (SAR) can offer an efficient approach to identify promising …
[HTML][HTML] Information technology in emergency management of COVID-19 outbreak
A Asadzadeh, S Pakkhoo, MM Saeidabad… - Informatics in medicine …, 2020 - Elsevier
Emergency management of the emerging infectious disease outbreak is critical for public
health threats. Currently, control of the COVID-19 outbreak is an international concern and …
health threats. Currently, control of the COVID-19 outbreak is an international concern and …
Repurposing of the approved small molecule drugs in order to inhibit SARS-CoV-2 S protein and human ACE2 interaction through virtual screening approaches
H Kalhor, S Sadeghi, H Abolhasani… - Journal of …, 2022 - Taylor & Francis
Most recently, the new coronavirus (SARS-CoV-2) has been recognized as a pandemic by
the World Health Organization (WHO) while this virus shares substantial similarity with …
the World Health Organization (WHO) while this virus shares substantial similarity with …
Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19)
The recent epidemic outbreak of a novel human coronavirus called SARS-CoV-2 and
causing the respiratory tract disease COVID-19 has reached worldwide resonance and a …
causing the respiratory tract disease COVID-19 has reached worldwide resonance and a …
Aloin isoforms (A and B) selectively inhibits proteolytic and deubiquitinating activity of papain like protease (PLpro) of SARS-CoV-2 in vitro
DSM Lewis, J Ho, S Wills, A Kawall, A Sharma… - Scientific reports, 2022 - nature.com
The most common host entry point of human adapted coronaviruses (CoV) including SARS-
CoV-2 is through the initial colonization in the nostril and mouth region which is responsible …
CoV-2 is through the initial colonization in the nostril and mouth region which is responsible …
Therapeutics for COVID-19: from computation to practices—where we are, where we are heading to
Abstract After the 1918 Spanish Flu pandemic caused by the H1N1 virus, the recent
coronavirus disease 2019 (COVID-19) brought us to the time of serious global health …
coronavirus disease 2019 (COVID-19) brought us to the time of serious global health …